位置:首页 > 蛋白库 > PRDX4_MOUSE
PRDX4_MOUSE
ID   PRDX4_MOUSE             Reviewed;         274 AA.
AC   O08807; B1AZS7; Q3U8E4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   03-AUG-2022, entry version 188.
DE   RecName: Full=Peroxiredoxin-4;
DE            EC=1.11.1.24 {ECO:0000250|UniProtKB:Q13162};
DE   AltName: Full=Antioxidant enzyme AOE372;
DE   AltName: Full=Peroxiredoxin IV;
DE            Short=Prx-IV;
DE   AltName: Full=Thioredoxin peroxidase AO372;
DE   AltName: Full=Thioredoxin-dependent peroxide reductase A0372;
DE   AltName: Full=Thioredoxin-dependent peroxiredoxin 4 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=Prdx4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=C57BL/6J;
RX   PubMed=11229364; DOI=10.1089/15230860050192288;
RA   Wong C.M., Chun A.C., Kok K.H., Zhou Y., Fung P.C., Kung H.F., Jeang K.-T.,
RA   Jin D.-Y.;
RT   "Characterization of human and mouse peroxiredoxin IV: evidence for
RT   inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive
RT   oxygen species.";
RL   Antioxid. Redox Signal. 2:507-518(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and DBA/2J; TISSUE=Bone marrow, and Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NMRI; TISSUE=Mammary gland, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 190-203 AND 216-226.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RA   Lubec G., Kang S.U., Yang J.W., Zigmond M.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), AND DISULFIDE BONDS.
RX   PubMed=23949117; DOI=10.1038/srep02456;
RA   Sato Y., Kojima R., Okumura M., Hagiwara M., Masui S., Maegawa K.,
RA   Saiki M., Horibe T., Suzuki M., Inaba K.;
RT   "Synergistic cooperation of PDI family members in peroxiredoxin 4-driven
RT   oxidative protein folding.";
RL   Sci. Rep. 3:2456-2456(2013).
CC   -!- FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of
CC       hydrogen peroxide and organic hydroperoxides to water and alcohols,
CC       respectively. Plays a role in cell protection against oxidative stress
CC       by detoxifying peroxides and as sensor of hydrogen peroxide-mediated
CC       signaling events (PubMed:11229364). Regulates the activation of NF-
CC       kappa-B in the cytosol by a modulation of I-kappa-B-alpha
CC       phosphorylation (By similarity). {ECO:0000250|UniProtKB:Q13162,
CC       ECO:0000269|PubMed:11229364}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + a hydroperoxide = [thioredoxin]-
CC         disulfide + an alcohol + H2O; Xref=Rhea:RHEA:62620, Rhea:RHEA-
CC         COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:30879, ChEBI:CHEBI:35924,
CC         ChEBI:CHEBI:50058; EC=1.11.1.24;
CC         Evidence={ECO:0000250|UniProtKB:Q13162};
CC   -!- SUBUNIT: Homodimer; disulfide-linked, upon oxidation. 5 homodimers
CC       assemble to form a ring-like decamer. {ECO:0000250|UniProtKB:Q13162}.
CC   -!- INTERACTION:
CC       O08807; Q8NBS9-1: TXNDC5; Xeno; NbExp=2; IntAct=EBI-494652, EBI-16091651;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13162}.
CC       Endoplasmic reticulum {ECO:0000250|UniProtKB:Q13162}. Note=Not
CC       secreted. {ECO:0000269|PubMed:11229364}.
CC   -!- PTM: The enzyme can be inactivated by further oxidation of the cysteine
CC       sulfenic acid (C(P)-SOH) to sulphinic acid (C(P)-SO2H) and sulphonic
CC       acid (C(P)-SO3H) instead of its condensation to a disulfide bond.
CC       {ECO:0000250|UniProtKB:Q13162}.
CC   -!- MISCELLANEOUS: The active site is a conserved redox-active cysteine
CC       residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic
CC       attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to
CC       cysteine sulfenic acid (C(P)-SOH), which then reacts with another
CC       cysteine residue, the resolving cysteine (C(R)), to form a disulfide
CC       bridge. The disulfide is subsequently reduced by an appropriate
CC       electron donor to complete the catalytic cycle. In this typical 2-Cys
CC       peroxiredoxin, C(R) is provided by the other dimeric subunit to form an
CC       intersubunit disulfide. The disulfide is subsequently reduced by
CC       thioredoxin. {ECO:0000250|UniProtKB:Q13162}.
CC   -!- SIMILARITY: Belongs to the peroxiredoxin family. AhpC/Prx1 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U96746; AAB57846.1; -; mRNA.
DR   EMBL; AK005031; BAB23758.1; -; mRNA.
DR   EMBL; AK146402; BAE27143.1; -; mRNA.
DR   EMBL; AK152255; BAE31074.1; -; mRNA.
DR   EMBL; BX005263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003349; AAH03349.1; -; mRNA.
DR   EMBL; BC019578; AAH19578.1; -; mRNA.
DR   CCDS; CCDS30496.1; -.
DR   RefSeq; NP_001300640.1; NM_001313711.1.
DR   RefSeq; NP_058044.1; NM_016764.5.
DR   PDB; 3VWU; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J=41-274.
DR   PDB; 3VWV; X-ray; 1.80 A; A/B=87-274.
DR   PDB; 3W8J; X-ray; 2.10 A; C/D=244-263.
DR   PDB; 3WGX; X-ray; 0.92 A; C/D=244-263.
DR   PDBsum; 3VWU; -.
DR   PDBsum; 3VWV; -.
DR   PDBsum; 3W8J; -.
DR   PDBsum; 3WGX; -.
DR   AlphaFoldDB; O08807; -.
DR   SMR; O08807; -.
DR   BioGRID; 207303; 21.
DR   DIP; DIP-34137N; -.
DR   IntAct; O08807; 9.
DR   MINT; O08807; -.
DR   STRING; 10090.ENSMUSP00000026328; -.
DR   PeroxiBase; 4532; Mm2CysPrx04.
DR   iPTMnet; O08807; -.
DR   PhosphoSitePlus; O08807; -.
DR   SwissPalm; O08807; -.
DR   REPRODUCTION-2DPAGE; O08807; -.
DR   CPTAC; non-CPTAC-3866; -.
DR   EPD; O08807; -.
DR   jPOST; O08807; -.
DR   MaxQB; O08807; -.
DR   PaxDb; O08807; -.
DR   PeptideAtlas; O08807; -.
DR   PRIDE; O08807; -.
DR   ProteomicsDB; 291790; -.
DR   Antibodypedia; 3275; 463 antibodies from 38 providers.
DR   DNASU; 53381; -.
DR   Ensembl; ENSMUST00000026328; ENSMUSP00000026328; ENSMUSG00000025289.
DR   GeneID; 53381; -.
DR   KEGG; mmu:53381; -.
DR   UCSC; uc009uru.1; mouse.
DR   CTD; 10549; -.
DR   MGI; MGI:1859815; Prdx4.
DR   VEuPathDB; HostDB:ENSMUSG00000025289; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   GeneTree; ENSGT00940000153430; -.
DR   HOGENOM; CLU_042529_21_1_1; -.
DR   InParanoid; O08807; -.
DR   OMA; EDSESCY; -.
DR   OrthoDB; 1326484at2759; -.
DR   PhylomeDB; O08807; -.
DR   TreeFam; TF105181; -.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 53381; 2 hits in 74 CRISPR screens.
DR   ChiTaRS; Prdx4; mouse.
DR   PRO; PR:O08807; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; O08807; protein.
DR   Bgee; ENSMUSG00000025289; Expressed in saccule of membranous labyrinth and 258 other tissues.
DR   ExpressionAtlas; O08807; baseline and differential.
DR   Genevisible; O08807; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:UniProtKB-EC.
DR   GO; GO:0045454; P:cell redox homeostasis; IGI:MGI.
DR   GO; GO:0030198; P:extracellular matrix organization; IGI:MGI.
DR   GO; GO:0008584; P:male gonad development; IMP:MGI.
DR   GO; GO:2000255; P:negative regulation of male germ cell proliferation; IMP:MGI.
DR   GO; GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IGI:MGI.
DR   GO; GO:0022417; P:protein maturation by protein folding; IGI:MGI.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IDA:MGI.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IMP:MGI.
DR   DisProt; DP02001; -.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; Oxidoreductase; Peroxidase;
KW   Redox-active center; Reference proteome; Signal.
FT   SIGNAL          1..40
FT                   /evidence="ECO:0000250"
FT   CHAIN           41..274
FT                   /note="Peroxiredoxin-4"
FT                   /id="PRO_0000135099"
FT   DOMAIN          82..240
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   ACT_SITE        127
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q13162"
FT   DISULFID        127
FT                   /note="Interchain (with C-248); in linked form"
FT                   /evidence="ECO:0000269|PubMed:23949117,
FT                   ECO:0007744|PDB:3VWU, ECO:0007744|PDB:3VWV"
FT   DISULFID        248
FT                   /note="Interchain (with C-127); in linked form"
FT                   /evidence="ECO:0000269|PubMed:23949117,
FT                   ECO:0007744|PDB:3VWU, ECO:0007744|PDB:3VWV"
FT   STRAND          92..97
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          100..105
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           106..109
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          112..118
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          122..126
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           129..136
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           138..143
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          146..154
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           156..163
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           167..169
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           186..190
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   TURN            196..199
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          204..208
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   STRAND          212..219
FT                   /evidence="ECO:0007829|PDB:3VWV"
FT   HELIX           226..244
FT                   /evidence="ECO:0007829|PDB:3VWV"
SQ   SEQUENCE   274 AA;  31053 MW;  73DB5374EC46241C CRC64;
     MEARSKLLDG TTASRRWTRK LVLLLPPLLL FLLRTESLQG LESDERFRTR ENECHFYAGG
     QVYPGEASRV SVADHSLHLS KAKISKPAPY WEGTAVINGE FKELKLTDYR GKYLVFFFYP
     LDFTFVCPTE IIAFGDRIEE FKSINTEVVA CSVDSQFTHL AWINTPRRQG GLGPIRIPLL
     SDLNHQISKD YGVYLEDSGH TLRGLFIIDD KGVLRQITLN DLPVGRSVDE TLRLVQAFQY
     TDKHGEVCPA GWKPGSETII PDPAGKLKYF DKLN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025